New Anti HPV E7 T Cells to Aid in HPV Research

research blog post
Human papillomavirus (HPV) is the most common sexually transmitted infection among Americans and although it can be prevented with a vaccine, only 60% of girls and 50% of boys in the U.S, had started the HPV vaccine series as of 2016.1Left untreated, HPV can cause cervical, head, and neck cancers among other health complications.More than 31,000 Americans are diagnosed with some form of cancer caused by an HPV infection, including 11,000 women diagnosed with cervical cancer. For 2 of the 3 types of cancer caused by HPV, there is no routine screening available, making HPV prevention even more critical.2

What Can Researchers Do?

Scientists have made many contributions to the study of the proteins produced by the human papillomavirus, including the E7 protein, which has been linked to the transformation of normal cells to cancerous cells.We recently developed a new addition to our exclusive collection of antigen-specific T cells to help researchers study HPV and develop future vaccinations and treatments. Our Anti HPV E7 T Cells have the potential to detect and kill tumor cells that carry the E7 protein and express the HLA-A*0201 antigen, both common in Americans infected with HPV.

Anti HPV E7 T Cells: Product Details

View more details on the product listing page and access the full Certificate of Analysis. 

Sources

1 https://www.cdc.gov/hpv/infographics/vacc-coverage.html2 https://www.cdc.gov/hpv/hcp/hpv-important.html

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.